3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
24
Colorectal Neoplasms
16
Small Cell Lung Carcinoma
6
Stomach Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Recurrence
3
Rectal Neoplasms
3
Osteosarcoma
3
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Wilms Tumor
1
Weight Loss
1
Triple Negative Breast Neoplasms
1
Somatostatinoma
1
Solid Tumor Cancer
1
Solid Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Interventions
Megestrol Acetate
7
Exercise
6
Standard of Care
4
Blood Specimen Collection
4
Olanzapine
3
Ibuprofen
3
dermcidin
2
Resistance Training
2
Physical Therapy Modalities
2
Nutrition Assessment
2
Mirtazapine
2
Melatonin
2
Enteral Nutrition
2
Diet Therapy
2
Cyproheptadine
2
testosterone enanthate
1
telotristat ethyl
1
remune
1
olanzapine-fluoxetine combination
1
nabiximols
1
nabilone
1
irinotecan sucrosofate
1
fucoidan
1
bermekimab
1
anamorelin
1
Vitamin D
1
Ultrasonography
1
Retrospective Studies
1
Radiotherapy
1
Powders
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cachexia
×
irinotecan sucrosofate
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled